Hematologic Malignancies

Hematologic malignancies include a broad spectrum of cancers affecting blood, bone marrow, and lymphatic tissues. This session explores advances in disease biology, diagnosis, molecular classification, targeted treatment, immunotherapy, cellular therapy, transplantation, monitoring, and resistance.

Abstract Scope and Participation

Submissions may address leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, myeloproliferative neoplasms, and other blood cancers. Topics involving molecular diagnostics, targeted agents, immunotherapy, cellular therapy, transplantation, minimal residual disease, and treatment outcomes are welcomed.